Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endothelium and coronary reactive hyperaemia

D Gattullo1, R J Linden, A Merletti

  • 1Dipartimento di Anatomia e Fisiologia Umana, Università degli Studi di Torino.

Bollettino Della Societa Italiana Di Biologia Sperimentale
|July 1, 1993
PubMed
Summary

Inhibition of nitric oxide (NO) release reduced the duration but not the peak amplitude of reactive hyperaemia following coronary occlusion in dogs. This suggests NO plays a key role in sustaining hyperaemic responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches.

GeroScience·2020
Same author

Apelin-induced cardioprotection against ischaemia/reperfusion injury: roles of epidermal growth factor and Src.

Acta physiologica (Oxford, England)·2017
Same author

Nanoprecipitated catestatin released from pharmacologically active microcarriers (PAMs) exerts pro-survival effects on MSC.

International journal of pharmaceutics·2016
Same author

Tissue engineering: chondrocyte cultures on type I collagen support. Cytohistological and immunohistochemical study.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology·2016
Same author

Redox signalling and cardioprotection: translatability and mechanism.

British journal of pharmacology·2014
Same author

Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia.

Leukemia·2013

Area of Science:

  • Cardiovascular Physiology
  • Vascular Biology
  • Nitric Oxide Research

Background:

  • Reactive hyperaemia is a transient increase in blood flow following a brief period of ischaemia.
  • Nitric oxide (NO) is a critical mediator of vascular tone and blood flow regulation.
  • The specific role of endothelial NO in the duration and amplitude of coronary reactive hyperaemia requires further elucidation.

Purpose of the Study:

  • To investigate the effect of inhibiting endothelial nitric oxide (NO) release on coronary reactive hyperaemia.
  • To determine the contribution of NO to the amplitude and duration of hyperaemic responses after coronary occlusion.

Main Methods:

  • Utilized an animal model (anaesthetized dogs).
  • Performed transient coronary artery occlusion (10 seconds).

Related Experiment Videos

  • Administered an intracoronary inhibitor of NO (LNNA) to block endothelial NO release.
  • Maintained constant aortic blood pressure throughout the experiment.

    • Main Results:

    • Peak amplitude of reactive hyperaemia remained unchanged after NO inhibition.
    • The duration of reactive hyperaemia was significantly reduced by approximately 50% following NO inhibition.
    • Suggests myogenic vasodilatation contributes to hyperaemia amplitude, while NO influences its duration.

    Conclusions:

    • Endothelial nitric oxide (NO) is crucial for sustaining the duration of coronary reactive hyperaemia.
    • Myogenic mechanisms are likely responsible for the peak amplitude of reactive hyperaemia.
    • Reduced shear stress-induced NO release may explain the shortened duration of hyperaemia after NO inhibition.